AltMountain

Windham Life Sciences Partners IV, L.P.

New York, NY · CIK 1999637

Windham Life Sciences Partners IV, L.P. is a venture capital fund based in New York, New York. According to its most recent Form D, filed Nov 9, 2026, it has sold $58,625,000 of interests to 83 investors since its first sale in Oct 2023. The minimum investment it accepts from an outside investor is $1. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Adam Fine; Windham Life Sciences Partners General Partner IV, LLC.

Total raised
$58,625,000Cumulative sales reported on Form D
Investors
83
First sale
Oct 27, 2023
Minimum investment
$1
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Adam Fine; Windham Life Sciences Partners General Partner IV, LLC
Latest Form D
Nov 9, 2026

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​‌​⁠

Raise history

$58,625,000Nov 3, 2023: $1,250,000 raisedNov 8, 2023: $1,250,000 raisedNov 15, 2024: $19,525,000 raisedNov 13, 2025: $30,784,955 raisedNov 9, 2026: $58,625,000 raisedNov 2023Nov 2026
FiledFilingTotal raisedInvestorsSource
Nov 9, 2026Form D/A (amendment)$58,625,00083SEC.gov ↗
Nov 13, 2025Form D/A (amendment)$30,784,95551SEC.gov ↗
Nov 15, 2024Form D/A (amendment)$19,525,00032SEC.gov ↗
Nov 8, 2023Form D/A (amendment)$1,250,0003SEC.gov ↗
Nov 3, 2023Form D$1,250,0003SEC.gov ↗

5 Form D filings in the SEC's electronic records (2008 onward), the earliest on Nov 3, 2023. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Windham Life Sciences Partners IV, L.P.

What is the minimum investment for Windham Life Sciences Partners IV, L.P.?

According to its latest Form D, filed Nov 9, 2026, the minimum investment Windham Life Sciences Partners IV, L.P. accepts from an outside investor is $1.

Who can invest in Windham Life Sciences Partners IV, L.P.?

Windham Life Sciences Partners IV, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Windham Life Sciences Partners IV, L.P. raised?

Windham Life Sciences Partners IV, L.P. reports $58,625,000 sold from 83 investors on its Form D filed Nov 9, 2026. This is cumulative sales since the offering began, not current assets or performance.

Where is Windham Life Sciences Partners IV, L.P. based?

Windham Life Sciences Partners IV, L.P. is based in New York, New York.

When did Windham Life Sciences Partners IV, L.P. launch?

Windham Life Sciences Partners IV, L.P. reports its first sale in Oct 2023.

Size compared with every venture capital fund

Raised more than 93% of the 1,246 venture capital funds based in New York, and more than 97% of all 14,864 that report sales.

More venture capital funds in New York

Similar-size venture capital funds in New York

All venture capital funds in New York